Tag Archives: CLLS

Best Performing Stocks To Own For 2019

Apple Inc. (NSDQ:AAPL)hasn’t been having its own way recently. A few months ago, the company wasordered to return $13 billion in back taxes in Europe plus now it has todeal with a new US president in Donald Trumpwho clearly has reservationson how Apple runs its business affairs. Recently though, the Irish government announced that it would be appealing the European Commission’s decision to seek back taxes from the tech giant. However, with Trump now the president-elect,the Nasdaq index in general was performing very well until it sold off by over 150 points on Thursday the 10th of November and recovered marginally by 30 points on Friday, November 11th. Apple (and other tech stocks) got caught up in the downswing only to recover slightly which has left us now with Apple trading at just over $108.43 a share. Here’s Why Apple stock is cheap at sub $110.

Best Performing Stocks To Own For 2019: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Cellectis SA (NASDAQ:CLLS) have earned an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

Best Performing Stocks To Own For 2019: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Westinghouse Air Brake Technologies (WAB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Samaha]

    On a more positive note, Flannery appears to be making ground on some key long-term objectives.

    Management feels “good” about the ability of the healthcare segment to outperform, according to Miller. Flannery claimed GE was in “active discussions” on some aviation platforms, current & lighting and distributed power, while an announcement on the divestment of transportation (rumored to be a target of Wabtec (NYSE:WAB)) is expected by the end of the second quarter. Structural cost reductions are now expected to be above the $2 billion target outlined on the investor day presentation in November 2017. Flannery outlined that he would lead the creation of a new operating system for GE based on “lean, six sigma ad agile” involving “continuous improvement and customer experience.”

    As a reminder, GE has promised $20 billion of asset sales, and the commentary on the earnings call was reassuring, particularly as the first deal (healthcare IT assets) was underwhelming.

  • [By Adam Levine-Weinberg]

    As part of its announcement on Tuesday, GE stated that its previous plan to divest about $20 billion of assets is “substantially complete.” Indeed, the company is set to receive $9.8 billion of cash proceeds over the next 12 months from four major asset sales, along with approximately $1.9 billion of Westinghouse Air Brake Technologies (NYSE:WAB) stock. GE shareholders will receive an additional $7.6 billion of Wabtec stock as part of the sale of the company’s freight locomotive business. The GE Lighting division is the last major asset up for sale under this plan.

  • [By Logan Wallace]

    Douglass Winthrop Advisors LLC purchased a new position in shares of Wabtec Co. (NYSE:WAB) during the first quarter, HoldingsChannel.com reports. The fund purchased 33,542 shares of the transportation company’s stock, valued at approximately $2,730,000.

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

Best Performing Stocks To Own For 2019: E*TRADE Financial Corporation(ETFC)

Advisors’ Opinion:

  • [By David Zeiler]

    In just three years, Robinhood’s customer base has surpassed that of entrenched online brokerage E*Trade Financial Corp. (Nasdaq: ETFC), which spent 35 years accumulating 3.6 million customers.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on E*TRADE Financial (ETFC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    New York State Teachers Retirement System cut its position in shares of E-Trade (NASDAQ:ETFC) by 1.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 501,653 shares of the financial services provider’s stock after selling 4,970 shares during the quarter. New York State Teachers Retirement System owned about 0.19% of E-Trade worth $27,797,000 as of its most recent filing with the Securities & Exchange Commission.

Best Performing Stocks To Own For 2019: Rosetta Resources Inc.(ROSE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Joseph Griffin]

    Rosehill Resources (NASDAQ:ROSE) Director Harry Quarls acquired 6,700 shares of Rosehill Resources stock in a transaction dated Thursday, May 17th. The shares were bought at an average cost of $8.15 per share, with a total value of $54,605.00. Following the transaction, the director now owns 53,189 shares in the company, valued at $433,490.35. The purchase was disclosed in a filing with the SEC, which is available through this link.

  • [By Max Byerly]

    Enbridge Energy Management (NYSE: EEQ) and Rosehill Resources (NASDAQ:ROSE) are both small-cap oils/energy companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Hot Low Price Stocks To Watch For 2019

Fasten your seat belts. Dramatic swings in the oil market may soon become the norm.

After a prolonged period of low prices and relative calm, oil watchers are predicting a surge of volatility following President Trump’s decision to reimpose sanctions on Iran. Crude has spiked 19% this year, to prices unseen since late 2014.

Taking away Iranian oil after production cuts by Venezuela, Saudi Arabia and Russia effectively means the margin for error in the market will become razor-thin.

In 2015 and 2016, there was so much supply that crude prices crashed. Now that buffer has been worn down so much that the market is extra-sensitive to geopolitical dangers and other shocks.

But that’s not all. Other powerful drivers are likely to jerk oil prices around, including the resurgent US dollar and a surge in production from Texas shale fields.

“Without a doubt, there are a variety of forces that could upset the balance and move us into a more volatile period,” said Ben Cook, portfolio manager at BP Capital Fund Advisors, an energy investment firm.

Hot Low Price Stocks To Watch For 2019: ARMOUR Residential REIT, Inc.(ARR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Wells Fargo & Company MN decreased its position in shares of ARMOUR Residential REIT, Inc. (NYSE:ARR) by 19.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 201,989 shares of the real estate investment trust’s stock after selling 50,292 shares during the period. Wells Fargo & Company MN owned about 0.48% of ARMOUR Residential REIT worth $4,703,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    ARMOUR Residential REIT, Inc. (NYSE:ARR) declared a monthly dividend on Wednesday, May 30th, Wall Street Journal reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.19 per share by the real estate investment trust on Thursday, June 28th. This represents a $2.28 annualized dividend and a dividend yield of 9.72%. The ex-dividend date is Thursday, June 14th.

  • [By Joseph Griffin]

    ARMOUR Residential REIT (NYSE:ARR) was the target of some unusual options trading activity on Thursday. Stock traders acquired 657 call options on the stock. This represents an increase of approximately 1,163% compared to the typical volume of 52 call options.

Hot Low Price Stocks To Watch For 2019: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Cellectis SA (NASDAQ:CLLS) have earned an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

Hot Low Price Stocks To Watch For 2019: Navios Maritime Holdings Inc.(NM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Navios Maritime (NM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Navios Maritime (NYSE: NM) is one of 44 public companies in the “Deep sea foreign transportation of freight” industry, but how does it contrast to its peers? We will compare Navios Maritime to similar companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

  • [By Lisa Levin]

    Navios Maritime Holdings Inc. (NYSE: NM) is estimated to report quarterly loss at $0.23 per share on revenue of $128.00 million.

    Virtusa Corporation (NASDAQ: VRTU) is projected to report quarterly earnings at $0.55 per share on revenue of $279.85 million.

Hot Low Price Stocks To Watch For 2019: Shopify Inc.(SHOP)

Advisors’ Opinion:

  • [By Danny Vena, George Budwell, and Daniel Miller]

    With that in mind, we asked three Motley Fool contributors to identify growth stocks with intriguing potential that might not be on the radar of most investors. They pickedShopify Inc. (NYSE:SHOP), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), and Criteo S.A. (NASDAQ:CRTO).

  • [By Danny Vena]

    Shopify (NYSE:SHOP) had a lot to prove going into its most recent earnings release. While the company continued to increase revenue and add merchants at a torrid pace, a noted short-seller had the company back in its crosshairs, claiming that the recent data scandal at Facebookwould make it harder to recruit new merchants. Investors were also questioning whether the company could continue at the breakneck speed it had established over the last several years.

  • [By Rich Duprey, Rich Smith, and Travis Hoium]

    Since going public in mid-2015,e-commerce platform developer Shopify (NYSE:SHOP) has nearly quintupled in value, for around a 60% annual compounded growth rate. Of course, predicting those kinds of returns is impossible, but Shopify’s business model represents a unique opportunity that hit the market at just the right time.

  • [By Logan Wallace]

    These are some of the news articles that may have effected Accern Sentiment Analysis’s scoring:

    Get Shopify alerts:

    Why Investors Ought to be Careful with Shopify Inc. (baystreet.ca) Shopify review (techradar.com) Is Shopify Inc. (TSX:SHOP) Headed for a Big Correction? (fool.ca) Shopify (SHOP) Expected to Announce Quarterly Sales of $234.69 Million (americanbankingnews.com) How to sustain Canada’s brain gain (theglobeandmail.com)

    A number of analysts have recently weighed in on SHOP shares. National Bank Financial raised their price objective on Shopify from $150.00 to $160.00 and gave the stock an “outperform” rating in a research report on Friday, February 16th. Zacks Investment Research raised Shopify from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 17th. Vetr raised Shopify from a “buy” rating to a “strong-buy” rating and set a $159.15 price objective for the company in a research report on Monday, March 26th. DA Davidson raised their price objective on Shopify to $130.00 and gave the stock a “neutral” rating in a research report on Thursday, May 10th. Finally, Morgan Stanley raised their price objective on Shopify from $120.00 to $140.00 and gave the stock an “equal weight” rating in a research report on Friday, February 16th. Eleven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $135.86.

Hot Low Price Stocks To Watch For 2019: Monolithic Power Systems, Inc.(MPWR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Monolithic Power Systems (MPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of Monolithic Power Systems, Inc. (NASDAQ:MPWR) reached a new 52-week high and low on Wednesday after Deutsche Bank raised their price target on the stock from $130.00 to $140.00. Deutsche Bank currently has a buy rating on the stock. Monolithic Power Systems traded as low as $137.03 and last traded at $136.43, with a volume of 4470 shares trading hands. The stock had previously closed at $136.41.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Monolithic Power Systems (MPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    News headlines about Monolithic Power Systems (NASDAQ:MPWR) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Monolithic Power Systems earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.1278970459044 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Hot Low Price Stocks To Watch For 2019: ICON plc(ICLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Senomyx (NASDAQ: SNMX) and ICON (NASDAQ:ICLR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

  • [By Lee Jackson]

    Icon
    Based in Ireland, this top company is offering investors a nice entry point. Icon PLC (NASDAQ: ICLR) is a global contract research organization (CRO) providing clinical development services to pharmaceutical, biotechnology and medical device industries.

  • [By Stephan Byrd]

    Financial Gravity Wealth Inc. acquired a new position in shares of Icon Plc (NASDAQ:ICLR) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,524 shares of the medical research company’s stock, valued at approximately $179,000.

  • [By Joseph Griffin]

    Icon Plc (NASDAQ:ICLR) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $127.20.

  • [By Joseph Griffin]

    Icon Plc (NASDAQ:ICLR) – Stock analysts at KeyCorp increased their Q4 2018 earnings estimates for Icon in a research note issued on Sunday, June 17th. KeyCorp analyst D. Hooker now forecasts that the medical research company will earn $1.59 per share for the quarter, up from their previous estimate of $1.58. KeyCorp currently has a “Overweight” rating and a $152.00 price target on the stock.

Top 5 Blue Chip Stocks To Invest In Right Now

One of the most difficult aspects of trading is timing the market. Odds are if you have been in the market over the past nine years, most likely you made some money. This bull market began in March of 2009, and 24/7 Wall St. is looking back to see how some major blue chip stocks compared to the broad markets over this time.

Back on March 6, 2009, the S&P 500 bottomed out at 666.79, and from there began perhaps the biggest bull market of the modern era. At the most recent close, the S&P 500 was at 2,677.67, more than quadrupling its bottom nearly nine years ago.

So how does Goldman Sachs Group Inc. (NYSE: GS) compare to the markets over the past nine years?

On an adjusted close basis, Goldman Sachs ended March 6, 2009, at $72.89 a share, or $81.72 on an unadjusted basis. Goldman Sachs most recently closed at $256.78 on an adjusted basis.

Checking the numbers, its fairly obvious that Goldman Sachss growth over this period has lagged the broad markets, with shares gaining only 250%. If you had invested $1,000 in Goldman Sachs back then, you would have just $3,522.84 as of Thursdays close.

Top 5 Blue Chip Stocks To Invest In Right Now: Itron Inc.(ITRI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Itron (NASDAQ:ITRI) major shareholder Scopia Capital Management Lp purchased 114,129 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was purchased at an average price of $59.34 per share, for a total transaction of $6,772,414.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

  • [By Stephan Byrd]

    Itron (NASDAQ: ITRI) and Data I/O (NASDAQ:DAIO) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
    Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
    Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
    Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
    Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
    Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
    Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
    Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
    VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
    Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
    Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
    YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Itron (ITRI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Data I/O (NASDAQ: DAIO) and Itron (NASDAQ:ITRI) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Itron (ITRI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Invest In Right Now: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Shane Hupp]

    FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.

    Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).

Top 5 Blue Chip Stocks To Invest In Right Now: ICON plc(ICLR)

Advisors’ Opinion:

  • [By Lee Jackson]

    Icon
    Based in Ireland, this top company is offering investors a nice entry point. Icon PLC (NASDAQ: ICLR) is a global contract research organization (CRO) providing clinical development services to pharmaceutical, biotechnology and medical device industries.

  • [By Logan Wallace]

    Senomyx (NASDAQ: SNMX) and ICON (NASDAQ:ICLR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

  • [By Joseph Griffin]

    Icon Plc (NASDAQ:ICLR) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $127.20.

  • [By Stephan Byrd]

    Financial Gravity Wealth Inc. acquired a new position in shares of Icon Plc (NASDAQ:ICLR) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,524 shares of the medical research company’s stock, valued at approximately $179,000.

Top 5 Blue Chip Stocks To Invest In Right Now: Electronics for Imaging Inc.(EFII)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Electronics For Imaging (EFII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Natixis Advisors L.P. lifted its stake in Electronics For Imaging, Inc. (NASDAQ:EFII) by 20.1% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,439 shares of the technology company’s stock after buying an additional 3,582 shares during the quarter. Natixis Advisors L.P.’s holdings in Electronics For Imaging were worth $586,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Joseph Griffin]

    Metropolitan Life Insurance Co. NY lessened its holdings in shares of Electronics For Imaging, Inc. (NASDAQ:EFII) by 53.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 14,882 shares of the technology company’s stock after selling 17,018 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Electronics For Imaging were worth $439,000 at the end of the most recent reporting period.

Top 5 Blue Chip Stocks To Invest In Right Now: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Cellectis SA (NASDAQ:CLLS) have earned an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

Best Dividend Stocks To Buy For 2019

Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Profitability

Get Prudential alerts:

This table compares Prudential and Reinsurance Group of America’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Prudential N/A N/A N/A
Reinsurance Group of America 14.01% 8.04% 1.17%

Dividends

Prudential pays an annual dividend of $1.81 per share and has a dividend yield of 3.5%. Reinsurance Group of America pays an annual dividend of $2.00 per share and has a dividend yield of 1.3%. Prudential pays out 48.4% of its earnings in the form of a dividend. Reinsurance Group of America pays out 18.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Reinsurance Group of America has increased its dividend for 7 consecutive years.

Best Dividend Stocks To Buy For 2019: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Cellectis SA (NASDAQ:CLLS) have earned an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

Best Dividend Stocks To Buy For 2019: Chesapeake Energy Corporation(CHK)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By Dan Caplinger]

    The stock market stayed in a pretty narrow range on Thursday, climbing early in the session but then slowly drifting lower through the afternoon hours. In the absence of major news, investors largely looked forward to key events like trade negotiations among the world’s largest economies. Other financial markets saw mixed moves as well, with 10-year Treasury yields climbing above 3.1% while oil prices stayed comfortably above $70 per barrel. Despite the quiet day, some companies had good news that pushed their shares sharply higher. World Wrestling Entertainment (NYSE:WWE), Chesapeake Energy (NYSE:CHK), and Williams Partners (NYSE:WPZ) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.1% to $77.53, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 1.1%, at $3.16 in a 52-week range of $2.53 to $6.18. EOG Resources Inc. (NYSE: EOG) traded down about 0.2% to $109.21. The 52-week range is $81.99 to $119.00.

    In addition, the United States Natural Gas ETF (NYSEAMERICAN: UNG) traded up about 0.7%, at $222.17 in a 52-week range of $20.40 to $31.72.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacting to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.7%, at $80.03 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 0.5% to $3.00, in a 52-week range of $2.53 to $5.87. EOG Resources Inc. (NYSE: EOG) traded up about 1.6% at $117.19. The 52-week range is $81.99 to $119.00.

    In addition, the United States Natural Gas ETF (NYSEARCA: UNG) traded up about 0.7% at $23.08 in a 52-week range of $20.40 to $31.72.

  • [By ]

    Chesapeake Energy (CHK) : “No. That’s natural gas, and we’ve got too much of it in this country.”

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

Best Dividend Stocks To Buy For 2019: Affimed N.V.(AFMD)

Advisors’ Opinion:

  • [By Chris Lange]

    Affimed N.V. (NASDAQ: AFMD) shares dropped sharply early on Friday after the company released new results from its early stage trial with Keytruda. Affimed presented new interim data from the Phase 1b dose escalation study evaluating AFM13, its lead NK cell engager candidate, at the European Hematology Association (EHA) 23rd Congress in Stockholm, Sweden

Best Stocks To Invest In Right Now

Tesla (NASDAQ:TSLA) reported fourth-quarter earnings last month, and one notable line item on the balance sheet was a sequential increase in the carrying value of its inventory. At the end of 2016, the electric-car maker had nearly $2.1 billion in inventory, a sequential increase from $1.6 billion in the prior quarter.

The breakdown of inventory isn’t disclosed until the subsequent 10-Q or 10-K is filed after earnings, and Tesla filed its 10-K earlier this month. Investors can now see the moving parts.

Tesla is now sitting on $1 billion in finished goods

For starters, here’s a breakdown of Tesla’s inventory for the past two quarters.

Inventory

Q3 2016

Q4 2016

Raw materials

$353.8 million

$680.3 million

Work in process

Best Stocks To Invest In Right Now: Medidata Solutions, Inc.(MDSO)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Veeva Systems outperformingunderperforming small cap peerModel N Inc (NYSE: MODN) while mid cap Medidata Solutions (NASDAQ: MDSO) has been a huge outperformer that has just moved past its 2014 peak:

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).

Best Stocks To Invest In Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

Best Stocks To Invest In Right Now: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, small cap clinical-stage biopharmaceutical stock Cellectis SA (NASDAQ: CLLS) reported that they had received notice fromFDA that a clinical hold was placed on both UCART123 ongoing Phase 1 studies -in acute myeloid leukemia (AML) and in blastic plasmacytoid dendritic cell neoplasm (BPDCN). The clinical hold was initiated after Cellectis reported one fatality in the BPDCN clinical trial (ABC study) with the Company now working closelywith the investigators and the FDA in order to resume the trials with an amended protocol including a lowered dosing of UCART123. The FDA has a detailed page about clinical holds which mentions:

  • [By Lisa Levin]

    Cellectis SA (ADR) (NASDAQ: CLLS) shares dropped 20 percent to $25.70 after announcing FDA clinical hold of UCART123 studies.

    Shares of Opiant Pharmaceuticals Inc (NASDAQ: OPNT) were down 10 percent to $35.20. Opiant Pharma named David O'Toole as CFO.

Best Stocks To Invest In Right Now: Popular, Inc.(BPOP)

Advisors’ Opinion:

  • [By Peter Graham]

    Founded in 1893, mid cap Popular Inc (NASDAQ: BPOP) is the leading banking institution by both assets and deposits in Puerto Rico and ranks among the top 50 U.S. banks by assets. Popular provides retail, mortgage and commercial banking services through its principal banking subsidiary, Banco Popular de Puerto Rico, as well as auto and equipment leasing and financing, investment banking, broker-dealer and insurance services through specialized subsidiaries. In the United States, Popular has established a community-banking franchise providing a broad range of financial services and products with branches in New York, New Jersey and Florida under the name of Popular Community Bank.

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).